Celularity Growth, Revenue, Number of Employees and Funding

Overview

Location:
Warren, NJ USA
Total Funding:$367.7M
Industry:Biotech
Founded:2016
Lead Investor(s):N/A
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Revenue & Financials

    0
  • Celularity received $250.0M in venture funding in February 2018.
  • 0
  • Celularity's total funding is $367.7M.

Employee Data

  • Celularity has 145 Employees.
  • Celularity grew their employee count by 31% last year.
  • Celularity currently has 9 job openings.

What Is Celularity?

POSTPARTUM PLACENTA: THE FOUNDATION OF OUR SCIENCE - Celularity scientists were the first to recognize the human placenta as an untapped resource for innovation, one which is the basis of Celularity innovations in immuno-oncology, hematology, and regenerative medicine. Our seminal discovery of unique stem, progenitor, and immune cells from the placenta is the foundation of our dominating intellectual property position. With proprietary platform technology and operational expertise to harness the power of this remarkable organ, we developed a deep therapeutic pipeline across a broad range of indications. AMPLIFYING THE BODYS ABILITY TO REGENERATE - Celularity combines innovative assets and research in cell therapy, functional regeneration, and biosourcing to develop leading therapeutic products and services that treat serious, life-threatening diseases. We are harnessing the unique cells and biomaterials from the postpartum placenta to provide therapies that amplify the body's ability to fight disease, heal, and regenerate itself. For more information visit our website at www.celularity.com

keywords:N/A

145

Number of Employees

N/A

Revenue (est)

9

Current Jobs

31%

Employee Growth %

$367.7M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
GENEWIZ
$75.8M5196%
Hitachi Chemica...
$29.9M22919%
GENEWIZ
$75.8M5196%
Hitachi Chemica...
$29.9M22919%
Canfield Scient...
$29.3M2048%
Thomas Scientif...
$21.5M16720%
Canfield Scient...
$29.3M2048%
Thomas Scientif...
$21.5M16720%
L Oreal USA
N/A5227%
L Oreal USA
N/A5227%

Celularity News

27-Feb-19 - First Clinical Results Evaluating Allogeneic, Off-The-Shelf, Placental

First Clinical Results Evaluating Allogeneic, Off-The-Shelf, Placental-Derived Cells to be Presented by Celularity at 2019 AACR Annual

25-Feb-19 - Former Apple CEO John Sculley On Exponential Time, And Living To

Sculley is also involved in a company called Celularity, serving as vice-chairman of the board of directors. Celularity is a biotech company that

31-Aug-18 - Celularity Acquires CariCord, Inc., Adds Important Biosourcing Assets

Celularity Acquires CariCord, Inc., Adds Important Biosourcing Assets, Strategic Relationship with the University of Colorado's ClinImmune

Celularity Funding

DateAmountRoundLead InvestorsReference
2018-02-16$250.0MUndisclosedMultipleArticle

Celularity Acquisitions

DateCompany NameAmountNotesReference
2018-09-04CariCordArticle